GlassScriptPhysician profile
Mohammed A Alawad
NPI 1952357436
$1,108.05
in general payments reported to CMS, 2019-2025
16 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.69 · 2020: $33.23 · 2021: $132 · 2022: $91.88 · 2023: $196 · 2024: $276 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $277.00 | 2023-2025 | |
| Pfizer INC. | $167.60 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $122.93 | 2022-2025 | Farxiga |
| Glaxosmithkline, LLC. | $105.28 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Sanofi-Aventis U.S. LLC | $87.83 | 2019-2025 | |
| Phathom Pharmaceuticals, INC. | $61.84 | 2025 | Voquezna |
| Abbvie INC. | $41.72 | 2022-2025 | |
| Dexcom, INC. | $27.74 | 2023 | Dexcom G6 Transmitter |
| Preventric Diagnostics, INC. | $20.49 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.21 | 2025 | Jardiance |
| Exact Sciences Corporation | $17.86 | 2025 | The Cologuard Plus Collection Kit |
| Currax Pharmaceuticals LLC | $16.71 | 2025 | Contrave |
| Amgen INC. | $15.92 | 2020 | |
| Novo Nordisk INC | $13.76 | 2024 | Wegovy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Alawad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.